BioIVT has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. The acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.   “With the addition of Keystone Biologicals, BioIVT broadens its product offerings and better supports clients in the in vitro diagnostic (IVD) market,” said BioIVT Chief Executive Officer Jeffrey Gatz. “This acquisition furthers our mission of becoming the partner of choice...